Cite

    Hall, S., Lambourne, B., Aynsley, E., Gardiner, J., Greystoke, A., Hughes, A., Jones, C., Leaning, D., Li, L., Mansy, T., Margetts, J., Mcdonald, F., Mcmenemin, R., Mulvenna, P., Peedell, C., Shakespeare, D., Simmons, T., Singhal, S., & Turnbull, H. (n.d.). 57 Crizotinib in clinical practice: the North East of England's experience. Lung cancer, 91, S21–. http://access.bl.uk/ark:/81055/vdc_100030532200.0x00001d